The JPG is the voice of the Japanese life sciences industry in the UK, made up of companies whose global HQs are based in Japan.
- Our members employ approximately 3,000 people across UK affiliates, European HQs and research and manufacturing
- JPG companies bring the best of Japanese innovation to UK patients
- We also invest in UK life sciences, being involved in various research partnerships in the UK, actively scouting for scientific opportunities and have significant investments in UK biotech and clinical trials
- In 2024/5 JPG members
- Made 35 significant investments in UK biotech, plus two company acquisitions
- Invested in over 50 academic programmes across multiple universities in England, Scotland and Wales
- Participated in more than 10 cross sector research collaborations
- Engaged in 25 early-stage trials and over 60 late-stage, including real world and post-marketing studies
- Supported over 10 charitable research foundations
- Our ambition is to partner with Government to increase Japanese investment in the UK ecosystem and an important part of this is our roundtable event bringing together Government, leaders in UK Life Sciences and the global heads of R&D in our member companies
- In addition to delivering a successful event, our current priorities are implementation of the Independent Review of Clinical trials, evolution of MHRA as a sovereign regulator and implementation of the 2024 VPAG, particularly the Investment Programme.